ACC CardiaCast: The Intersection of CVD and Type 2 Diabetes: The Role of SGLT2 Inhibitors and GLP-1 RAs in Cardiology

In this episode, Christopher Granger is joined by endocrinologist Jennifer Green to discuss the role of GLP-1 receptor agonists and SGLT2 inhibitors in cardiology, what cardiologists need to know to use these drugs safely and effectively, and how important it is to understand their role in the use of these drugs.

Visit the CVRiD: Applying Emerging Science to Practice Hub to listen to the other episodes in the series and to access other educational content.

Subscribe on Apple Podcasts | Subscribe on Google Play

Clinical Topics: Diabetes and Cardiometabolic Disease, Prevention

Keywords: CardiaCast, Primary Prevention, Metabolic Syndrome X, Diabetes Mellitus, Type 2, Cardiovascular Diseases


< Back to Listings